Reason for Notification: Update to earlier Notification - posted to the website on 11th June 2026
Further to the notice posted on 11th June 2026, the NVRL will be moving routine testing of plasma for CMV and EBV DNA to the Roche Cobas® system.
Samples received at the NVRL from 31st July 2026 will be tested on this platform.
For Paediatric patients: please note that a larger sample volume is required for these assays, where possible please send one tube for EBV and one for CMV.
